1 / 15

Trends in Cord Blood and Haplo-Identical Transplants: 2014 Insights

This report explores the latest trends in cord blood transplants and haplo-identical (Haplo) transplants from 2014. It highlights significant data on U.S. cord blood use, trends in transplantation by patient demographics, and the steady growth of Haplo as a cell source. While Haplo transplants are the fastest-growing category, they still represent less than 2% of all transplants. The findings also discuss the impact of Haplo on minority populations and investigate whether the rise in Haplo transplants has influenced a decline in cord blood transplant rates.

umay
Télécharger la présentation

Trends in Cord Blood and Haplo-Identical Transplants: 2014 Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NetCord Update – 2014 - Milano Michael Boo National Marrow Donor Program/Be The Match

  2. Cord Transplants

  3. Cord Shipments

  4. Cord Blood Use Trend in US - WMDA

  5. International Cord Blood Unit ActivityBy Calendar Year

  6. International Cord Blood Unit ActivityFor Fiscal Year 2014 Ending February 28

  7. Cord Transplants by Patient Race for Fiscal Year to Date December 2013

  8. Domestic Cord Transplants by Patient Race for Fiscal Year to Date December 2013

  9. Cord Transplants by Patient Agefor Fiscal Year to Date December 2013

  10. Steady growth of Haplo Transplants in recent years

  11. “Haplo” is the fastest growing cell source but still is less than 2% of all transplants

  12. Diseases treated by Haplo-identical Transplants

  13. Haplo cell source does not appear to benefit any specific age group compared to URD Tx

  14. Haplo donors appear to benefit minorities the most

  15. Has the growth in HaploTx caused the recent decline in CB Tx?

More Related